Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
PMID 14554208
Impact of GLP-1 Receptor Agonists on Alcohol-Related Liver Disease Development and Progression in Alcohol Use Disorder
Always consult your doctor or medical care provider if you are considering any kind of treatment for diabetes and/or weight loss
Gi2-protein-mediated signal transduction: central nervous system molecular mechanism countering the development of sodium-dependent hypertension
Back to Journals Drug Design, Development and Therapy Volume 17 Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis Authors Xue H, Xing HJ, Wang B, Fu C, Zhang YS, Qiao X, Guo C, Zhang XL, Hu B, Zhao X, Deng LJ, Zhu XC, Zhang Y , Liu YF Received 19 January 2023 Accepted for publication 4 May 2023 Published 11 May 2023 Volume 2023:17 Pages 14171432 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Qiongyu Guo Huan Xue, 1, * Hao-Jie Xing, 1, * Bin Wang, 1 Chao Fu, 1 Yu-Shan Zhang, 1 Xi Qiao, 1 Chao Guo, 1 Xiao-Li Zhang, 1 Bin Hu, 1 Xin Zhao, 1 Li-Jiao Deng, 1 Xiao-Chan Zhu, 1 Yi Zhang, 1 Yun-Feng Liu 2 1 Department of Pharmacology, Shanxi Medical University, Taiyuan, 030001, Peoples Republic of China
The supernatant was incubated at 20 C for 48 h or longer
US$ 23.37
US$ 26.38
US$ 21.73
US$ 21.85
US$ 22.78
US$ 20.63
